

Powering innovation in medical care through our precision microbiome science
Driven to discover
Our approach to microbiome analysis is enabling new discoveries and advancing the understanding of the microbiome in health and disease.
At Microba Life Sciences, we believe comprehensive and precise measurement of the human gut microbiome is required to drive innovation in medical care. Through our powerful analysis and discovery platforms, we are identifying novel microbiome-derived therapeutics and new diagnostic tools to advance medicine.
Our growing team is built on a foundation of scientific and technical excellence and a drive to discover ever-deeper insights into the relationships between gut microorganisms and health. We are continually increasing and refining the precision of our analysis, and we believe in working with international partners who share our passion and scientific rigour to fast-track these new advances.
In short, we believe in transforming human health by harnessing the gut microbiome, and we are leading life-changing microbiome discoveries based on ever more precise analysis of the microbiome.
Our innovative team


Professor Gene Tyson

Professor Philip Hugenholtz

Associate Professor Lutz Krause

Dr Luke Reid

Professor Trent Munro

Dr Nicola Angel

Dr Páraic Ó Cuív

Dr Alena Pribyl

James Heath

Pasquale Rombola

Jacqueline Fernley

Associate Professor Jake Begun

Associate Professor Paul Griffin

Bernie Woodcroft

Dr David Wood

Dr Areej Alsheikh

Michael Wood

Hayley Parcell

Dr Paula Smith-Brown

Richard Bund

Dr Hyungtae Kim

Mark Capone

Drew Webb

Associate Professor Chris Hogan
Our foundations in microbiome science
Our Co-founders, Professor Gene Tyson and Professor Philip Hugenholtz, are recognised world leaders in their fields who pioneered major advancements in metagenomics and set new standards for the classification of microorganisms.

Professor Philip Hugenholtz
